JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
University of Mississippi Medical Center
IntoCell, Inc
OHSU Knight Cancer Institute
Second Life Therapeutics
Onchilles Pharma Inc
The First Affiliated Hospital of Guangzhou Medical University
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
D'Or Institute for Research and Education
University Hospital, Brest
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Samsung Medical Center